Impact of Multi-component Interventions on Populations With Mental Health

Status Not yet recruiting

Clinical Trial Summary

Study Participants: High-risk COPD population with mental health symptoms, defined as individuals whose score of COPD-SQ ≥ 16, whose age is 35 and above, and whose Warwick-Edinburgh Mental Well-being Scale <45 . Intervention: We have constructed a pay-for-population mechanism for medical practitioners within the intervention townships to encourage them caring for population health. For study participants in the intervention arm, we will ask them to finish an online COPD-SQ questionnaire with notification of his or her COPD high risk status. For those with high-risk COPD population, we will provide face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For high-risk COPD population with mental health issues in the intervention arm, we provide community-based spirometry pulmonary function test (PFT) and education; If individuals whose post-bronchodilator FEV1/FVC<0.7, they will be spirometry-defined COPD patients and will be encouraged to seek treatment and medication to the superior hospitals. A CBT-based digital health intervention program, EmoEase, will be provided to our study participants with an intelligent mobile phone. Also health education in terms of mental health issues will be given. Additionally, we provide (1) a digital health intervention programs to smokers; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12. Comparison: Those who are assigned in the control arm, we will ask them to finish the same COPD-SQ online questionnaire with notification of his or her COPD high risk status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given. Outcomes: The primary outcomes are PHQ-9 scores for depression symptoms, GAD-7 symptoms for anxiety symptoms, and WEM-WBS score at month 12.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06458218
Study type	Interventional
Source	Peking Union Medical College
Contact	Simiao Chen, Ph.D.
Phone	010-65104915
Email	simiao.chen@uni-heidelberg.de
Status	Not yet recruiting
Phase	N/A
Start date	June 17, 2024
Completion date	October 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05777044` - The Effect of Hatha Yoga on Mental Health	N/A
Recruiting	`NCT05064293` - Assisted Identification and Navigation of Early Mental Health Symptoms in Children	N/A
Not yet recruiting	`NCT05886595` - Being Young : My Mental Health
Active, not recruiting	`NCT05903638` - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility	N/A
Not yet recruiting	`NCT04030858` - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery	N/A
Recruiting	`NCT04926675` - Development of a Money Advice Intervention Within IAPT	N/A
Recruiting	`NCT06105970` - Chinese Community Sample of Hierarchical Model of Psychopathology
Recruiting	`NCT06038721` - Unified Protocol: Community Connections	N/A
Completed	`NCT05056428` - Effects of Mindfulness Training on Emotional Care Strategies	N/A
Not yet recruiting	`NCT04978194` - Effects of an Intervention on University Students' Mental Health and Learning During COVID-19	N/A
Recruiting	`NCT06144905` - Norwegian Microbiota Study in Anorexia Nervosa
Completed	`NCT06080685` - Efficacy of Character Strengths Intervention in Enhancing Character Strengths and Self-esteem Among Adolescents	N/A
Not yet recruiting	`NCT06266936` - Smart Life Smart Living Intercontinental - Medical Students' Cohort
Not yet recruiting	`NCT06187701` - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients	N/A
Not yet recruiting	`NCT06430853` - Psychobiological Interventions in Pregnancy	N/A
Not yet recruiting	`NCT06006936` - Testing an Evidence-Based Self-Help Program for Infertility-Related Distress in Women	N/A
Not yet recruiting	`NCT05979649` - An Internet-Based Intervention With Peer Support for the Mental Health of Youths	N/A
Recruiting	`NCT05492305` - Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
Not yet recruiting	`NCT05316948` - Mental Health and Sexuality in Adolescents and Young Adults
Completed	`NCT05598697` - Economic Evaluation of the MEWE Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of Multi-component Interventions on Populations With Mental Health Symptoms and High-risk COPD — POPMIX-MH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms